Capital Development Program Sample Clauses

Capital Development Program. 10.02.1 Exhibit N-I and N-J (National) and Exhibit D-I and D-J (Dulles) summarize the Capital Development Program commenced by the Authority in 1988, including a listing of Projects, a description of the Projects, their priority status, their estimated costs, their estimated construction start and Substantial Completion Dates, and applicable Cost Center or Terminal or Equipment Sub-Centers. The Authority shall, from time to time, refine and update such Project descriptions. Such Project refinements may include the addition or deletion of components functionally related to the Capital Development Program; provided, however, that no such refinements shall materially change the scope of the Capital Development Program.
Sample 1Sample 2
AutoNDA by SimpleDocs
Capital Development Program. 10.02.1 Exhibits N-I and N-J (National) and Exhibit D- I and D-J (Dulles) summarize the Capital Development Program commenced by the Authority in 1988, including a listing of Projects, a description of the Projects, their priority status, their estimated costs, their estimated construction start and Substantial Completion Dates, and the applicable Cost Centers or Terminal or Equipment Sub-Centers. The Authority shall, from time to time, refine and update such Project descriptions. Such Project refinements may include the addition or deletion of components functionally related to the Capital Development Program; provided, however, that no such refinements shall materially change the scope of the Capital Development Program. 10.02.2 Subject to the issuance of Bonds, and the availability of the proceeds thereof, and to the provisions of Section 10.04 with respect to the Dulles Stage II Development Plan, the Authority shall complete the Projects of the Capital Development Program in a good and workmanlike manner, substantially in accordance with Exhibits N-J and D- J and the Project Construction Documents developed or to be developed by the Authority's Architects and Engineers for each Project, current copies of which are or will be on file at the Authority's offices. 10.02.3 The Authority shall provide the Airline information with respect to the Capital Development Program and an opportunity to consult on matters with respect thereto. This may be accomplished in the following manner The Signatory Airlines will establish, staff, and maintain an organization known as the Metropolitan Washington Airlines Committee ("MWAC"). The Airline may designate its representative to MWAC. The seven largest Signatory Airlines, as determined by reference to the combined landed weight at the two Airports, will constitute an executive committee of the MWAC, provided that the executive committee includes at least one domestic airline from each Airport and at least one foreign flag airline at Dulles. The executive committee of MWAC shall designate an individual to serve as a representative for all Scheduled Air Carriers ("Airline Representative") to the Authority with respect to the construction and operational impact of all Projects described in the Capital Development Program and all Additional Projects. (i) The Authority shall afford the Airline Representative access to all construction sites relating to the Capital Development Program and an opportunity to participate in the ...
Sample 1

Related to Capital Development Program

  • Initial Development Plan Not later than the Effective Date, Licensee shall have provided Merck with an initial Development plan for the Licensed Product in the Field in the Territory, which shall be incorporated as part of this Agreement as Attachment 3.02(a) (as may be amended in accordance with this Agreement, the “Development Plan”). **CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.

  • Clinical Development Licensee will have sole responsibility for and sole decision making over the clinical development of any Product arising from the Research Program in the Field. Notwithstanding the foregoing, if Licensee wishes to conduct clinical development of a Development Candidate at Penn and Penn has the clinical expertise, interest and ability to run such a trial as assessed at Penn’s sole discretion, such a study will be conducted under a separate Clinical Trial Agreement to be negotiated by the Parties prior to initiation of such study. Such separate clinical trial agreement will include a detailed clinical development plan, including costs and time lines for conducting the Clinical Trial.

  • Development Program A. Development activities to be undertaken (Please break activities into subunits with the date of completion of major milestones)

  • Development Funding (a) Viewray will pay 3D Line the then U.S. Dollar equivalent of €[***] within three (3) days of the Effective Date for the engineering services required to develop/ deliver the Deliverable described in Section 2.1(a)(i).

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Contract Area, including its abandonment.

  • Collaboration Management Promptly after the Effective Date, each Party will appoint a person who will oversee day-to-day contact between the Parties for all matters related to the management of the Collaboration Activities in between meetings of the JSC and will have such other responsibilities as the Parties may agree in writing after the Effective Date. One person will be designated by Merck (the “Merck Program Director”) and one person will be designated by Moderna (the “Moderna Program Director,”) together will be the “Program Directors”. Each Party may replace its Program Director at any time by notice in writing to the other Party. Any Program Director may designate a substitute to temporarily perform the functions of that Program Director by written notice to the other Party. The initial Program Directors will be: For Moderna: [***] For Merck: [***]

  • Research and Development (i) Advice and assistance in relation to research and development of Party B;

  • Commercialization Plan On a Product by Product basis, not later than sixty (60) days after the filing of the first application for Regulatory Approval of a Product in the Copromotion Territory, the MSC shall prepare and approve a rolling multiyear (not less than three (3) years) plan for Commercializing such Product in the Copromotion Territory (the "Copromotion Territory Commercialization Plan"), which plan includes a comprehensive market development, marketing, sales, supply and distribution strategy for such Product in the Copromotion Territory. The Copromotion Territory Commercialization Plan shall be updated by the MSC at least once each calendar year such that it addresses no less than the three (3) upcoming years. Not later than thirty (30) days after the filing of the first application for Regulatory Approval of a Product in the Copromotion Territory and thereafter on or before September 30 of each calendar year, the MSC shall prepare an annual commercialization plan and budget (the "Annual Commercialization Plan and Budget"), which plan is based on the then current Copromotion Territory Commercialization Plan and includes a comprehensive market development, marketing, sales, supply and distribution strategy, including an overall budget for anticipated marketing, promotion and sales efforts in the upcoming calendar year (the first such Annual Development Plan and Budget shall cover the remainder of the calendar year in which such Product is anticipated to be approved plus the first full calendar year thereafter). The Annual Commercialization Plan and Budget will specify which Target Markets and distribution channels each Party shall devote its respective Promotion efforts towards, the personnel and other resources to be devoted by each Party to such efforts, the number and positioning of Details to be performed by each Party, as well as market and sales forecasts and related operating expenses, for the Product in each country of the Copromotion Territory, and budgets for projected Pre-Marketing Expenses, Sales and Marketing Expenses and Post-Approval Research and Regulatory Expenses. In preparing and updating the Copromotion Territory Commercialization Plan and each Annual Commercialization Plan and Budget, the MSC will take into consideration factors such as market conditions, regulatory issues and competition.

  • Development Plans 4.3.1 For each Licensed Indication and corresponding Licensed Product in the Field, Licensee will prepare and deliver to Licensor a development plan and budget (each a “Development Plan”). The initial Development Plans for each Licensed Indication will be delivered within […***…] after the Grant Date for such Licensed Indication.

  • Joint Development If joint development is involved, the Recipient agrees to follow the latest edition of FTA Circular 7050.1, “Federal Transit Administration Guidance on Joint Development.”

Time is Money Join Law Insider Premium to draft better contracts faster.